FIELD: medicine.
SUBSTANCE: group of inventions relates to the treatment of schizophrenia. A combination for the prevention, relief or treatment of schizophrenia includes (a) a carbamate compound of the following formula 1 or its pharmaceutically acceptable salt, solvate or hydrate; and (b) aripiprazole or its pharmaceutically acceptable salt, solvate or hydrate: 
[formula 1], in which each R1 and R2 is independently selected from a group consisting of hydrogen, halogen and C1-C8 alkyl; and one of A1 and A2 is CH, and the other is N. A pharmaceutical composition for the prevention, relief or treatment of schizophrenia is also disclosed.
EFFECT: group of inventions provides for improved effect without an increase in side effects.
17 cl, 1 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USING CANNABINOIDS COMBINED WITH ANTIPSYCHOTIC DRUG PREPARATION | 2008 |
|
RU2503448C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING WATER-INSOLUBLE ANTIPSYCHOTIC DRUG AND SORBITAN ESTERS | 2012 |
|
RU2757859C2 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING WATER-INSOLUBLE ANTIPSYCHOTIC AGENT AND SORBITAN ESTERS | 2012 |
|
RU2627469C2 |
| METHODS FOR USING CYCLIC AMIDE DERIVATIVES FOR TREATING SCHIZOPHRENIA | 2011 |
|
RU2576611C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2785871C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2728787C2 |
| NEW METHODS | 2014 |
|
RU2682658C1 |
| USING ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISEASES, INCREASE NEUROPLASTICITY AND PROMOTE NEUROPROTECTION | 2019 |
|
RU2812786C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTIPSYCHOTIC DRUG AND A VMAT2 INHIBITOR, AND THEIR USE | 2015 |
|
RU2757221C2 |
| APPLICATION OF 10-HYDROXY-10,11-DIHYDROCARBAMAZEPINE DERIVATIVES FOR TREATMENT OF AFFECTIVE DISORDERS | 2004 |
|
RU2367440C2 |
